LOXL3 and idiopathic pulmonary fibrosis: Additionally, LOXL3 has been involved in idiopathic pulmonary fibrosis (IPF), a chronic disease characterized by uncontrolled and excessive accumulation of ECM and consequent severe lung dysfunction (Figure 5d).